The mRNA technology enables quick and flexible responses to new variants of pathogens and rapid scale-up in production, said one researcher.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Transforming mRNA therapeutics into clinical realities requires easy and fast access to synthetic DNA in the design-build-test-learn iteration cycle. This is one of the rate-limiting steps that ...

Harnessing the power of mRNA, a naturally occurring molecule that tells the body how to make a protein, experts in the field ...

Combining AI-driven design with rapid, cell-free DNA synthesis, researchers are turning mRNA into a scalable solution for vaccines, cancer treatments, and personalized genetic therapies.

Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug ...

With the possibility of Robert F. Kennedy, Jr. being involved in health policy in the next administration, vaccination – especially mRNA vaccines – will become a hot topic. Is there anything to fear ...

Contrary to claims on social media, COVID-19 vaccines using messenger RNA (mRNA) technology do not transform recipients from humans into “hybrids,” nor do they alter human DNA through ...

An mRNA vaccine has certain advantages over a DNA vaccine, which has to use a re-engineered virus or other delivery mechanism to make it through the membrane that protects the nucleus of a cell.

This Snapshot feature explains how DNA vaccines work, the differences between DNA and mRNA vaccines, and why DNA vaccines are so promising.